Advanced Medical Solutions Group (LON:AMS) Sets New 52-Week High – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS) hit a new 52-week high during mid-day trading on Thursday. The company traded as high as GBX 284.50 and last traded at GBX 283.01, with a volume of 357,783 shares traded. The stock had previously closed at GBX 283.

Advanced Medical Solutions Group Stock Performance

The firm has a market capitalization of £616.37 million, a price-to-earnings ratio of 171.52, a P/E/G ratio of 5.00 and a beta of 0.75. The company has a quick ratio of 4.58, a current ratio of 2.94 and a debt-to-equity ratio of 33.60. The business has a 50-day moving average of GBX 281.93 and a two-hundred day moving average of GBX 248.07.

Advanced Medical Solutions Group (LON:AMS) last posted its earnings results on Wednesday, September 16th. The company reported GBX 6.39 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 1.58% and a return on equity of 1.44%. Research analysts predict that Advanced Medical Solutions Group plc will post 9.82 EPS for the current fiscal year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.